Health Care and Pharma | Research Reports, News, Events, Research on Demand

Research Reports Titles

  • China Laboratory Information System (LIS) Sales Market Report 2021

    This report studies sales (consumption) of Laboratory Information System (LIS) in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering Sunquest Information Systems (U.S.) Cerner Corporation (U.S.) SSC Soft Computer (U.S.) CompuGroup Medical AG (Germany) McKesson Corporation (U.S.) Epic Systems Corporation (U.S.) Medical Information Technology (U.S.) Orchard Software Corporation (U.S.) Computer Programs and Systems (CPSI) (U.S.) Merge Healthcare (U.S.) Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Laboratory Information System (LIS) in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: August 08, 2016
    • Price: USD 3200
    • Format: PDF

  • Global OCR Automated Fare Collection System Market Professional Survey Report 2016

    Notes: Production, means the output of OCR Automated Fare Collection System Revenue, means the sales value of OCR Automated Fare Collection System This report studies OCR Automated Fare Collection System in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Cubic Transportation GMV Kvsio GRGBanking Genfare Avail Technologies, Inc Magnadata International ... By types, the market can be split into Type I Type II Type III By Application, the market can be split into Application 1 Application 2 Application 3 By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India

    • Release Date: August 08, 2016
    • Price: USD 3500
    • Format: PDF

  • Global Pneumococcal Vaccine Market 2016-2020

    About Pneumococcus Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000 children under five years) every year. It can be prevented by vaccination and involves the introduction of a dead or weakened antigen into the human body. This produces lymphocytes to counter the infection and any future invasions by that antigen. Technavio s analysts forecast the global pneumococcal vaccine market to grow at a CAGR of 13.69% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global pneumococcal vaccine market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent pneumococcal infections. The market is divided into the following segments based on geography: " Americas " APAC " EMEA Technavio's report, Global Pneumococcal Vaccine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors " GlaxoSmithKline (GSK) " Merck " Pfizer " Sanofi Other prominent vendors " Abera " AstraZeneca " Baxter " Beijing Minhai Biotechnology " Biken " Biogen " Celgene " Eli Lilly " Genentech " Genocea Biosciences " ImmunoBiology " Lupin " Nuron Biotech " Panacea Biotec (India) " S K Chemicals " Serum Institute of India " Sinovac " Valneva Austria Market driver " Inclusion in NIP " For a full, detailed list, view our report Market challenge " Inadequate vaccine coverage " For a full, detailed list, view our report Market trend " Expansion of marketing territories " For a full, detailed list, view our report Key questions answered in this report " What will the market size be in 2020 and what will the growth rate be? " What are the key market trends? " What is driving this market? " What are the challenges to market growth? " Who are the key vendors in this market space? " What are the market opportunities and threats faced by the key vendors? " What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst s time when you purchase this market report. Details are provided within the report.

    • Release Date: August 01, 2016
    • Price: USD 2500
    • Format: PDF

  • Global Pain Management Drugs Market 2016-2020

    About Pain Pain is defined as a complex medical problem that can have profound effects not only on one's physical but also mental well-being. Pain management is a branch of medicine, which employs approach for easing the suffering and improving the quality of life of individuals suffering from pain. It can be simple or complex type, depending on the cause of pain. Pain management comprises of a variety of skills and techniques used for the treatment of pain. Technavio s analysts forecast the global pain management drugs market to grow at a CAGR of 4.97% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global pain management drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs that are used for the management of pain. The market is divided into the following segments based on geography: " Americas " APAC " EMEA Technavio's report, Global Pain Management Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors " AstraZeneca " Endo International " Johnson & Johnson " Pfizer " Purdue Pharma Other prominent vendors " Allergan " AstraZeneca " Baxter " Bayer " Boehringer Ingelheim " Bristol-Myers Squibb " Durect " GlaxoSmithKline " Hospira " Merck " Novartis " Pain Therapeutics " F. Hoffmann-La Roche " Sanofi " UCB " Valeant " Taro Pharmaceuticals " Achelios Therapeutics " Alder Biopharmace-uticals " Amgen " CoLucid " Daiichi Sankyo " Dr. Reddy's Laboratories " Eli Lilly " GW Pharmaceuticals " Immune Pharmaceuticals " Innovative Med Concepts " NeurAxon " OptiNose " RedHill " Sorrento Therapeutics " SUDA " Teva " Tonix " Trigemina " WEX Pharmaceuticals " Zynerba Pharmaceuticals Market driver " Increase in awareness of pain management drugs " For a full, detailed list, view our report Market challenge " Preference for alternative therapies " For a full, detailed list, view our report Market trend " Off-label drug usage " For a full, detailed list, view our report Key questions answered in this report " What will the market size be in 2020 and what will the growth rate be? " What are the key market trends? " What is driving this market? " What are the challenges to market growth? " Who are the key vendors in this market space? " What are the market opportunities and threats faced by the key vendors? " What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst s time when you purchase this market report. Details are provided within the report.

    • Release Date: August 01, 2016
    • Price: USD 2500
    • Format: PDF

  • Osteoporosis? - Market Insights, Epidemiology and Market Forecast-2023

    DelveInsight s Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Osteoporosis for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Osteoporosis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Osteoporosis till 2023. Key Coverage and Benefits " The report will help in developing business strategies by understanding the trends shaping and driving the global Osteoporosis market. " Identifying patient populations in the global  Osteoporosis market to improve product design, pricing, and launch plans. " Organize sales and marketing efforts by identifying the best opportunities for Osteoporosis therapeutics in each of the markets covered. " To understand the future market competition in the global Osteoporosis therapeutics market and Insightful review of the key market drivers and barriers. Scope " Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. " Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023. " The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023. " It also provides Osteoporosis for United States, EU5 and Japan from 2013 and forecasted Market to 2023. Note: This report requires 7-10 business days to complete.

    • Release Date: August 01, 2016
    • Price: USD 4950
    • Format: pdf

  • Peripheral Arterial Disease - Market Insights, Epidemiology and Market Forecast-2023

    DelveInsight s Peripheral Arterial Disease - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Peripheral Arterial Disease for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Peripheral Arterial Disease forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Peripheral Arterial Disease till 2023. Key Coverage and Benefits " The report will help in developing business strategies by understanding the trends shaping and driving the global Peripheral Arterial Disease market. " Identifying patient populations in the global  Peripheral Arterial Disease market to improve product design, pricing, and launch plans. " Organize sales and marketing efforts by identifying the best opportunities for Peripheral Arterial Disease therapeutics in each of the markets covered. " To understand the future market competition in the global Peripheral Arterial Disease therapeutics market and Insightful review of the key market drivers and barriers. Scope " Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. " Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023. " The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023. " It also provides Peripheral Arterial Disease for United States, EU5 and Japan from 2013 and forecasted Market to 2023. Note: This report requires 7-10 business days to complete.

    • Release Date: August 01, 2016
    • Price: USD 4950
    • Format: pdf

  • Urinary Incontinence? - Market Insights, Epidemiology and Market Forecast-2023

    DelveInsight s Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Urinary Incontinence for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Urinary Incontinence forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Urinary Incontinence till 2023. Key Coverage and Benefits " The report will help in developing business strategies by understanding the trends shaping and driving the global Urinary Incontinence market. " Identifying patient populations in the global  Urinary Incontinence market to improve product design, pricing, and launch plans. " Organize sales and marketing efforts by identifying the best opportunities for Urinary Incontinence therapeutics in each of the markets covered. " To understand the future market competition in the global Urinary Incontinence therapeutics market and Insightful review of the key market drivers and barriers. Scope " Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. " Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023. " The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023. " It also provides Urinary Incontinence for United States, EU5 and Japan from 2013 and forecasted Market to 2023. Note: This report requires 7-10 business days to complete.

    • Release Date: August 01, 2016
    • Price: USD 4950
    • Format: pdf

  • Growth Hormone Deficiency (GHD)? - Market Insights, Epidemiology and Market Forecast-2023

    DelveInsight s Growth Hormone Deficiency (GHD) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Growth Hormone Deficiency (GHD) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Growth Hormone Deficiency (GHD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Growth Hormone Deficiency (GHD) till 2023. Key Coverage and Benefits " The report will help in developing business strategies by understanding the trends shaping and driving the global Growth Hormone Deficiency (GHD) market. " Identifying patient populations in the global  Growth Hormone Deficiency (GHD) market to improve product design, pricing, and launch plans. " Organize sales and marketing efforts by identifying the best opportunities for Growth Hormone Deficiency (GHD) therapeutics in each of the markets covered. " To understand the future market competition in the global Growth Hormone Deficiency (GHD) therapeutics market and Insightful review of the key market drivers and barriers. Scope " Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. " Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023. " The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023. " It also provides Growth Hormone Deficiency (GHD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023. Note: This report requires 7-10 business days to complete.

    • Release Date: August 01, 2016
    • Price: USD 4950
    • Format: pdf

  • Myocardial Infarction? - Market Insights, Epidemiology and Market Forecast-2023

    DelveInsight s Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Myocardial Infarction for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Myocardial Infarction forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Myocardial Infarction till 2023. Key Coverage and Benefits " The report will help in developing business strategies by understanding the trends shaping and driving the global Myocardial Infarction market. " Identifying patient populations in the global  Myocardial Infarction market to improve product design, pricing, and launch plans. " Organize sales and marketing efforts by identifying the best opportunities for Myocardial Infarction therapeutics in each of the markets covered. " To understand the future market competition in the global Myocardial Infarction therapeutics market and Insightful review of the key market drivers and barriers. Scope " Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. " Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023. " The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023. " It also provides Myocardial Infarction for United States, EU5 and Japan from 2013 and forecasted Market to 2023. Note: This report requires 7-10 business days to complete.

    • Release Date: August 01, 2016
    • Price: USD 4950
    • Format: pdf


Create Account



Log In Your Account